TABLE 2.
Source | Residues | Antibodya | Peptide and oligonucleotide sequences | Reference(s) |
---|---|---|---|---|
gD protein of HSV | 272–279 | MAb DL6 | Gly Pro Glu Asp Pro Glu Asp Ser Ala Leu Leu Gly Pro | 29 |
CCG GAA GAC CCG GAA GAC TCC GCT CTG CTG GGG GCC | ||||
C CGG GGC CTT CTG GGC CTT CTG AGG CGA GAC GAC CC | ||||
C GAA GAC CCG GAA GAC TCC GCT CTG CTG GGG CC | ||||
CC GGG CTT CTG GGC CTT CTG AGG CGA GAC GAC C | ||||
gD protein of HSV | 11–19 | MAb 1D3 | Gly Pro Met Ala Asp Pro Asn Arg Phe Arg Gly Gly Pro | 14, 29 |
CCG ATG GCT GAC CCG AAC CGT TTC CGT GGT GGG GCC | ||||
C CGG GGC TAC CGA CTG GGC TTG GCA AAG GCA CCA CC | ||||
C ATG GCT GAC CCG AAC CGT TTC CGT GGT GGG CC | ||||
CC GGG TAC CGA CTG GGC TTG GCA AAG GCA CCA C | ||||
Spike protein of TGEV | 379–388 | PAb anti-peptide S(379–388) | Gly Pro Ser Ser Phe Phe Ser Tyr Gly Glu Ile Pro Gly Pro | 10, 11 |
CCG TCC TCC TTC TTC TCC TAC GGT GAA ATC CCG GGG GCC | ||||
C CGG GGC AGG AGG AAG AAG AGG ATG CCA CTT TAG GGC CC | ||||
C TCC TCC TTC TTC TCC TAC GGT GAA ATC CCG GGG CC | ||||
CC GGG AGG AGG AAG AAG AGG ATG CCA CTT TAG GGC C |
PAb, polyclonal antibody.